MC LMS - 2025 ASKP3 Annual Conference: Upholding Integrity in Treatment: Navigating Responsibility, Standards and Scrutiny in a Critical Era

2025 ASKP3 Annual Conference: Upholding Integrity in Treatment: Navigating Responsibility, Standards and Scrutiny in a Critical Era

The 2025 Annual Conference theme, Upholding Integrity in Treatment: Navigating Responsibility, Standards, and Scrutiny in a Critical Era, reflects the pivotal moment we find ourselves in as practitioners in the ketamine field. Sessions were carefully curated as, together, we are shaping the future of safe, effective, and ethical care for patients in need.

Course Details

For Distributors

Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.

Quantity	Price per voucher
1+	$0.00

Navigating Responsibility, Standards, and Scrutiny in a Critical Era presented by Rupert McShane, MD	00:57:00
Undissociating With Ketamine-Assisted Psychotherapy presented by Chantelle Thomas, MD	00:46:00
Antisuicidal Effects of Ketamine: A Review of the Evidence and Future Directions presented by Brittany O'Brien, PhD	00:31:00
Ketamine Clinics: Legal Update	00:46:00
Modified Couples Ketamine Therapy for Primary and Secondary Post-Traumatic Stress Disorder	00:37:00
Foundation of Care: Outcomes From 2000 Patients, 4 IV Infusions, With an Escalating Dose Protocol	00:48:00
Panel Discussion: Insights into Navigating the Evolving Regulatory Landscape	00:45:00
Stellate Ganglion Block (SGB) as an Adjunct to Ketamine Therapy	00:51:00
Payor Reimbursement - Documentation, Coding and Billing, and Audit Trend	00:56:00
Moving the Needle on Insurance Coverage for Ketamine for Mental Health and Chronic Pain	00:34:00
Building Community & Shaping the Future of Ketamine Assisted Psychotherapy Together: Updates From the ASKP3 Therapist Advisory Panel	00:15:00
Sub-Dissociative Dose Ketamine: Eleven Novel Applications	00:50:00
Ketamine & Esketamine for Bipolar Disorder	00:42:00
How (Not What) to Prescribe: Integrating Drug and Non-Drug Aspects of Dissociative Therapies	00:50:00
Ketamine and Neurotoxicity	00:31:00
ASKP3 Expert Faculty Update	00:46:00
Misuse Potential of Ketamine and Relationship With Other Substance Use: Real-World Evidence	00:41:00
Panel: Areas of Controversy - A Deep Dive Discussion of ASKP3 Public Statements on Home Use and Treatment in the Setting of Comorbid Substance Use	00:53:00